Presentation is loading. Please wait.

Presentation is loading. Please wait.

Metrology for the “Fate” of Nanoparticles in Biosystems

Similar presentations


Presentation on theme: "Metrology for the “Fate” of Nanoparticles in Biosystems"— Presentation transcript:

1 Metrology for the “Fate” of Nanoparticles in Biosystems
Michael T. Postek, Andras Vladar, Thomas LeBrun and John Dagata, MEL John Small, John Henry Scott, Scott Wight, Peter Barker, CSTL Alamgir Karim, Jack Douglas, Matthew Becker, Vincent Hackley, Andrew Allen, Stephanie Hooker, MSEL

2 MEL MSEL CSTL Metrology for the “Fate” of Nanoparticles
Michael T. Postek, Champion Andras Vladar Thomas LeBrun John Dagata, Alamgir Karim, Champion Jack Douglas Matthew Becker Vincent Hackley Andrew Allen Stephanie Hooker John Small, Champion John Henry Scott Scott Wight, Peter Barker

3 Metrology for the “Fate” of Nanoparticles
Competence proposal is motivated by work stemming from: National Nanotechnology Initiative Subcommittee on Nanoscale Science, Engineering and Technology (NSET) Michael Postek Alamgir Karim Nanotechnology Environmental and Health Implications Working Group (NEHI WG) John Small The National Institute for Occupational Safety and Health (NIOSH) Andrew Maynard (endorsement) Environmental Protection Agency (EPA) Barbara Karn Nora Savage …. “I would anticipate a highly successful project, and one that will support research into the impact of nanotechnology in a significant manner.” ……. Andrew Maynard, NIOSH

4 Why Now…Impact on Society, Environment,
and Commerce NIST is the only organization that has the mission and the necessary combination of staff expertise, experience, industry contacts, industry respect, & worldwide recognition as the leading measurement and standards institution to address the high risk scientific and technological challenges associated with developing the measurement techniques and technical standards needed in this new field. National Nanotechnology Initiative, pg 119. Without NIST’s contributions….. the lack of a common infrastructure for bioscience measurements, standards, & data will constrain innovation and stifle the commercialization of new bioscience-based applications in health care, agriculture and food, environmental protection, homeland security, and many other areas. NIST 2010 Strategic Plan, pg 11. …A joint collaboration with the National Institute of Standards and Technology (NIST) and the FDA is a high priority. The collaboration will focus on developing standards for nanoscale devices and both in vitro and in vivo characterization assays that could serve as a starting point for regulatory filings. Cancer Nanotechnology Plan, pg 24.

5 X Flawed Science Big PRESS
Why Now...Potential for Catastrophic Effects: Psychological and Economic NANOTECHNOLOGY RESEARCH GRANTS INVESTIGATING ENVIRONMENTAL AND HUMAN HEALTH EFFECTS OF MANUFACTURED NANOMATERIALS: A JOINT RESEARCH SOLICITATION-EPA, NSF, NIOSH Basically a toxicology study of nanoparticles Need for known characterized particles Need for standardized methodology X Flawed Science Big PRESS This approach will not reassure the public at large For Science, Nanotech Poses Big Unknowns By Rick Weiss Washington Post Staff Writer Sunday, February 1, 2004; Page A01 Materials Today July/Aug 2003: 64 Animal studies are mixed Polish study found little effect U.S. study found many rats died early and lung granulomas Wing Lam of Wyle Laboratories in Houston David Warheit at DuPont Co.'s Haskell Laboratory (15% died within 24 hours!) Appears more toxic than quartz. What materials were used? Asbestos diseases often take over 20 years to show up!

6 NIST’s Role Why NIST…Lack of Measurement Infrastructure has
Become a Critical Hurdle to Further Innovation “Instrumentation and metrology crosscut all the NNI Grand Challenges, and are vital to the success of the NNI. Advances in fundamental nanoscience, design of new nano-materials, and ultimately manufacturing of new nanoscale products will all depend to some degree on the capability to accurately and reproducibly measure properties and performance characteristics at the nanoscale. VALUE CREATION (IMPACT): Productivity / Market Access / Public Safety & Welfare March 2004 Standards Development (Phase II) Measurement Methods & Tools (Phase I) Basic Science NIST’s Role A new product development toolkit containing powerful new scientific and technical methods ……. is urgently needed to improve predictability and efficiency along the critical path from laboratory concept to commercial product. Scientific Discovery New Invention Period Technology Improvement Period S&T DEVELOPMENT OVER TIME *Office of Cellular, Tissue, and Gene Therapies

7 It is this simple - what is the difference?
Micrometer sized particles of Zinc Oxide Left Right FDA approval of zinc oxide nanoparticles is “grandfathered” in because of the previous approvals for micrometer-sized particles… … discussion held at the first NEHI meeting What is the effect on the body? Right Nanometer sized particles of Zinc Oxide Primary Particle size of 3-10 nm

8 Competence Goal What we want to do: What we are not doing:
Develop an innovative toolbox for metrology of nanoparticles in biological systems that currently does not exist Focused Ion Beam sectioning Cryo TEM/SEM/FIB stage integration Cryomicrotomy ….. Form a strong group of experts in biological nanoparticle analysis Develop an unbiased source of expertise Provide better technical support for other agencies What we are not doing: Attempting to become NIH Losing our metrology focus

9 Why Nanoparticle Metrology for Biological Systems?
Motivation Why Nanoparticle Metrology for Biological Systems? Nanoparticles are being produced and are a part of our environment Nanoparticle measurements are challenging Biological samples must be carefully prepared Validation procedures are needed for standardization of measurements NIST needs to develop competence in this area NIST can make a difference Why 3D chemical imaging? New technologies are creating more characterization problems that cannot be solved by traditional 2D and point analysis methods These problems are found over a wide variety of current and future nanotechnologies including: semiconductors, optoelectronics, data storage, catalysts, pigments, nano-composites, powder metallurgy and ceramics, wear-resistant and thermal coatings, biomaterials, etc. Many devices and components are now smaller than our analytical sampling volume. Requires deconvolution of matrix or adjacent components 3D analysis is the best approach to solve this problem Why now? New enabling technologies: Electron microscope optics, detectors, stage automation, computing power, instrument stability

10 Outline Measurement Challenge Technical Strategy Issues and Barriers Dissemination of Results Milestones Resources and Leverages

11 Outline Measurement Challenge Technical Strategy Issues and Barriers Dissemination of Results Milestones Resources and Leverages

12 Nano-particle Life-Cycle
Underlying Basis for Measurement Need Effect of size Exposure/Uptake Bioactivity Transport Nano-particle Life-Cycle Depending upon the system, increased particle size can have either negative or positive consequences……. Particle size therefore can be indicator of expected activity. …. Mattison et al., 2001 “….An essential aspect of engineered nanomaterials is how their properties depend on physical and chemical structure. Quantitative assessments of the risk associated with engineered nanomaterials can not therefore proceed without techniques capable of providing biologically-relevant physiochemical information with nanometer resolution.” – Andrew Maynard, NIOSH Control of mobility and distribution Surface chemistry effects

13 Challenge: Biological Sample Preparation
Biological samples require: Fixation Dehydration Embedding Sectioning Dual beam FIB Cryomicroscopy Cryomicrotomy Provides a new paradigm for NIST Physical metrology Biological sample preparation is not new to NIST, but not extensively practiced at NIST Biological samples require expertise that must be developed at NIST in order to assist our customers in metrology related situations.

14 Nanotubes (C, Au, Hybrid…)
Challenge: Diversity of Nanoparticles Presents Numerous Characterization Challenges Dendrimers Quantum Dots Nanotubes (C, Au, Hybrid…) SWNT DWNT MWNT These materials will be the first “in the pipeline” as new products but, new self-assembled soft material constructs with increasing difficult characterization challenges must be addressed Micelles Liposomes Functionalized Nanoparticles

15 Challenge: Numerous Measurement Parameters of Nanoparticles
particle diameter core diameter Core composition & stiffness shell thickness Molecular mass & distribution Surface chemistry & Extent of bio-functionality Aggregation number (# molecules per particle) Dispersion Properties Impacted by Measurable Parameters pH susceptibility Bioactivity Diffusion coefficient Anisotropic transport Membrane permeability Degradation mechanisms and byproducts

16 Challenge: Increasing Complexity
Fullerene decorated Dendrimer AW Jensen, BS Maru, X Zhang, DK Mohanty, BD Fahlman, DR Swanson, and DA Tomalia Nano Letters, 5(6), , 2005 Dendrimer decorated Polymer Brush Antibody labeled Gold Nanoshell CC Lee, M Yoshida, JMJ Frechet, EE Dy, and FC Szoka Bioconjugate Chem., 16(3), , 2005 C Loo, A Lowery, N Halas, J West, and R Drezek Nano Letters, 5 (4), , 2005

17 Small Changes Cause Enormous Differences in the Bioactivity
Challenge: High Measurement Precision of Surface Chemistry Small Changes Cause Enormous Differences in the Bioactivity Variable surface chemistry induces 6 orders of magnitude difference in toxicity profile CM Sayes, JD Fortner, W Guo, D Lyon, AM Boyd, KD Ausman, YJ Tao, B Sitharaman, LJ Wilson, JB Hughes, JL West, & VL Colvin “The Differential Cytotoxicity of Water-Soluble Fullerenes” Nano Letters, 4 (10), , 2004

18 Modeling is Imperative
Challenge: Multiple mechanisms of particle translocation Modeling is Imperative Computational approaches can help elucidate potential mechanisms of translocation

19 Outline Measurement Challenge Technical Strategy Issues and Barriers Dissemination of Results Milestones Resources and Leverages

20 Strategic Technical Approach
Bare Nanoparticle Characterization Cell Culture Sample Preparation Flocculation Particle Tracking Extra & Intra Cellular Nanoparticle Characterization Transport Properties Simulations Modeling

21 A Multi-laboratory Effort
Modeling Microscopy Cell Culture Specimen Preparation Analytical

22 Initial Test Nanoparticles and Metrology
Extracellular Metrology Intracellular Metrology Cell Culture Ultrastructure Particle Characterization TEM TEM (sectioned material) SEM SEM (sectioned material) FIB (sectioned material) Cryomicroscopy Dimensional Metrology DLS USAXS Particle Imaging Fluorescence AFM Transport Modeling x Particle Placement Optical Tweezers Particle Localization Particle Removal Gold nanoshell Quantum Dot

23 A Multi-laboratory Effort
Modeling Single Particle Analysis and Manipulation Microscopy Transmission Electron Microscopy NEW Aberration Corrected TEM Potential New NIST competence Scanning Electron Microscopy NEW Environmental SEM Optical Tweezers Single nanoparticle manipulation in biological materials Atomic Force Microscopy of biological materials 3-D reconstruction of cells and particles Nanometrology Cell Culture Specimen Preparation Analytical

24 A Multi-laboratory Effort
Modeling Single Particle Analysis and Manipulation Microscopy Transmission Electron Microscopy NEW Aberration Corrected TEM Potential New NIST competence Scanning Electron Microscopy NEW Environmental SEM Optical Tweezers Single nanoparticle manipulation in biological materials Atomic Force Microscopy of biological materials 3-D reconstruction of cells and particles STEM EDS maps with 50 nm resolution at 5mm WD C Fe Overlay Si K O Nanometrology Cell Culture Specimen Preparation Analytical

25 A Multi-laboratory Effort
NOVA Nanolab - dynamic sectioning of biological material for nanoparticle analysis and metrology Potential New NIST competence Biological sample preparation for electron microscopy Modeling Microscopy Nanometrology Focused Ion Beam NOVA Nanolab Biological Sample Preparation UMd Cell Culture Specimen Preparation Analytical

26 A Multi-laboratory Effort
FLOW-CELL SCHEMATIC Ultra-Small Angle X-ray Scattering (USAXS) Advantages of USAXS facility Probes dimensions from nm to µm scale with good statistics Small (adjustable) beam size (0.2 x 2 mm2) permits µL samples Absolute scattering cross-section permits quantitative analysis X-ray energy (wavelength) tunability High beam flux at sample (>1012 photons/s at 10 keV) USAXS SLIT-SMEARED GEOMETRY USAXS compliments the microscopy methods, providing statistically relevant data on populations of particles under in situ conditions Modeling Microscopy Nanometrology Cell Culture Specimen Preparation Analytical X-ray Scattering

27 A Multi-laboratory Effort
Dh = Hydrodynamic diameter of SCK Dynamic Light Scattering (DLS) Modeling Microscopy Nanometrology Cell Culture Specimen Preparation Analytical Dynamic Light Scattering

28 Outline Measurement Challenge Technical Strategy Issues and Barriers Dissemination of Results Milestones Resources and Leverages

29 Microscopy Measurements
Issues/Barriers Microscopy Measurements Dynamic Light Scattering (DLS) of particles results in the hydrodynamic diameter which is highly influenced by particle shape and solvation Sample preparation for complimentary electron beam techniques generally requires drying and good dispersal Images are highly influenced by electron beam interaction and charging effects Comparisons of DLS measurements with SEM, TEM and other techniques must be done But will result in different values. Resolution of these measurement differences is imperative Important part of this competence effort 5 nm size Pt particles in their original environment (fuel cell)

30 Issues/Barriers Modeling
Numerous proposed mechanisms and controversy in the scientific literature motivates intensive experimental and computational study of these types of assembly processes. Endocytosis and the Encapsulation of Nanoparticles by Clathrin Computational of Transport and Configurational Properties of Nanoparticles 3) Influence of Particle-Substrate Interactions on the Rate of Diffusion 4) Matrix-Driven Translocation of Nanoparticles There is currently no systematic experimental or computational approach to predict how nanoparticles might affect normal biological processes. Nanoparticle are unique in that they are commensurate in size with proteins & other biopolymers. This simple fact accounts for their high degree of bio-activity.

31 Manipulation of cells and liposome using optical tweezers
Issues/Barriers Can we actually manipulate the nanoparticles and place them where we want them? Fig. 6 Manipulation of cells and liposome using optical tweezers. Manipulation of cells and liposome using optical tweezers

32 Outline Measurement Challenge Technical Strategy Issues and Barriers Dissemination of Results Milestones Resources and Leverages

33 Technology Transfer and Dissemination
Direct interactions with manufacturers such as FEI Co., Gatan and others Alliances with FDA and NIH Nanotechnology Characterization Laboratory Addresses several of the NNI Program Component Areas Reported through the NNI Publications and presentations Workshops and conferences Web-based tools for modeling and computation

34 Measures of Success: Milestones
2006__ 2007__ 2008__ 2009__ 2010__ Intercomparison of metrology techniques Test particle uptake in cell cultures Demonstration of dual beam sectioning Initial nanoparticle transport model Demonstration of cryomicroscopy capabilities Demonstration of a robust measure of dispersion Demonstration of 3D reconstruction for biomedical applications 3D chemical and dimensional metrology of test nanoparticles Development of a 3D particle nanometrology infrastructure

35 Develop a 3D particle nanometrology
Summary This Competence at NIST will provide: Development of an innovative toolbox for metrology of nanoparticles in biological systems Currently does not exist A strong group of experts in biological sample preparation Unbiased source of expertise Unique technical support for other agencies Make NIST THE place where other agencies come FIRST GOAL: Develop a 3D particle nanometrology infrastructure by 2010

36 Outline Measurement Challenge Technical Strategy Issues and Barriers Dissemination of Results Milestones Resources and Leverages

37 Resource Requirements

38 Leverages Nanotechnology Characterization Laboratory collaboration in particle characterization and standardization Postek, Vladar, MEL Scott, Small, CSTL Hackley, MSEL Food and Drug Administration collaboration in nanoparticle coatings Karim, MSEL ATP Intramural Project Small, Postek Postek, Small 3-D Chemical Imaging Competence Scott, Small University of Maryland Laboratory for Ultrastructure Research FEI Company Hitachi High Technologies

39 Thank you

40 Thank you


Download ppt "Metrology for the “Fate” of Nanoparticles in Biosystems"

Similar presentations


Ads by Google